Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Rickman

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Cell Reports|December 21, 2017
Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell CycleGabriele Büchel, Anne Carstensen, Ka-Yan Mak, et al.
Neoplasia (New York, N.Y.)|March 23, 2019
Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic TargetRachel S Lee, Luxi Zhang, Adeline Berger, et al.
Plos Medicine|March 29, 2007
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimenPhilippe Bertheau, Elisabeth Turpin, David S Rickman, et al.
Neoplasia (New York, N.Y.)|August 4, 2009
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancerDorothee Pflueger, David S Rickman, Andrea Sboner, et al.
The Journal of Clinical Investigation|July 2, 2019
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancerAdeline Berger, Nicholas J Brady, Rohan Bareja, et al.
Nature Communications|June 8, 2021
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancerNicholas J Brady, Alyssa M Bagadion, Richa Singh, et al.
Nature Communications|November 26, 2014
ERG induces taxane resistance in castration-resistant prostate cancerGiuseppe Galletti, Alexandre Matov, Himisha Beltran, et al.
Genes, Chromosomes & Cancer|January 22, 2009
Distinct genomic aberrations associated with ERG rearranged prostate cancerFrancesca Demichelis, Sunita R Setlur, Rameen Beroukhim, et al.
Cancer Cell|October 12, 2016
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate CancerEtienne Dardenne, Himisha Beltran, Matteo Benelli, et al.
Molecular Cancer Research : MCR|June 22, 2026
ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancerFrancesca Lorenzin, Giulia Fracassi, Federico Vannuccini, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Cell Reports|December 21, 2017
Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell CycleGabriele Büchel, Anne Carstensen, Ka-Yan Mak, et al.
Neoplasia (New York, N.Y.)|March 23, 2019
Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic TargetRachel S Lee, Luxi Zhang, Adeline Berger, et al.
Plos Medicine|March 29, 2007
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimenPhilippe Bertheau, Elisabeth Turpin, David S Rickman, et al.
Neoplasia (New York, N.Y.)|August 4, 2009
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancerDorothee Pflueger, David S Rickman, Andrea Sboner, et al.
The Journal of Clinical Investigation|July 2, 2019
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancerAdeline Berger, Nicholas J Brady, Rohan Bareja, et al.
Nature Communications|June 8, 2021
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancerNicholas J Brady, Alyssa M Bagadion, Richa Singh, et al.
Nature Communications|November 26, 2014
ERG induces taxane resistance in castration-resistant prostate cancerGiuseppe Galletti, Alexandre Matov, Himisha Beltran, et al.
Genes, Chromosomes & Cancer|January 22, 2009
Distinct genomic aberrations associated with ERG rearranged prostate cancerFrancesca Demichelis, Sunita R Setlur, Rameen Beroukhim, et al.
Cancer Cell|October 12, 2016
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate CancerEtienne Dardenne, Himisha Beltran, Matteo Benelli, et al.
Molecular Cancer Research : MCR|June 22, 2026
ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancerFrancesca Lorenzin, Giulia Fracassi, Federico Vannuccini, et al.
Pageof 6